79 related articles for article (PubMed ID: 17113149)
1. Abnormal stromal cells in myelodysplastic syndromes: genomics presents further evidence.
Mayani H
Leuk Res; 2007 May; 31(5):577-8. PubMed ID: 17113149
[No Abstract] [Full Text] [Related]
2. Gene stage-specific expression in the microenvironment of pediatric myelodysplastic syndromes.
Roela RA; Carraro DM; Brentani HP; Kaiano JH; Simão DF; Guarnieiro R; Lopes LF; Borojevic R; Brentani MM
Leuk Res; 2007 May; 31(5):579-89. PubMed ID: 17092558
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow stroma in childhood myelodysplastic syndrome: composition, ability to sustain hematopoiesis in vitro, and altered gene expression.
Borojevic R; Roela RA; Rodarte RS; Thiago LS; Pasini FS; Conti FM; Rossi MI; Reis LF; Lopes LF; Brentani MM
Leuk Res; 2004 Aug; 28(8):831-44. PubMed ID: 15203281
[TBL] [Abstract][Full Text] [Related]
4. Expression and inducibility of cytoprotective heat shock proteins in the bone marrow of patients with myelodysplastic syndrome: correlation with disease progression.
Michalopoulou S; Micheva I; Karakantza M; Kouraklis-Symeonidis A; Mouzaki A; Zoumbos NC
Haematologica; 2006 Dec; 91(12):1714-6. PubMed ID: 17145614
[TBL] [Abstract][Full Text] [Related]
5. [Functional characteristics of hematopoietic and stromal cells in various forms of myelodysplastic syndrome].
Gerasimova LP; Manakova TE; Tsvetaeva NV; Lukina EA; Kozlovskaia AS
Biull Eksp Biol Med; 1999 Jan; 127(1):14-8. PubMed ID: 10189996
[No Abstract] [Full Text] [Related]
6. Molecular pathways in myelodysplastic syndromes and acute myeloid leukemia: relationships and distinctions-a review.
Bernasconi P
Br J Haematol; 2008 Sep; 142(5):695-708. PubMed ID: 18540941
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of gene expression profiling in myelodysplastic syndromes: recognition of ribosomal and translational gene dysregulation and development of predictive assays.
Galili N; Raza A
Best Pract Res Clin Haematol; 2009 Jun; 22(2):223-37. PubMed ID: 19698930
[TBL] [Abstract][Full Text] [Related]
8. Gene expression profiling in the myelodysplastic syndromes.
Pellagatti A; Fidler C; Wainscoat JS; Boultwood J
Hematology; 2005 Aug; 10(4):281-7. PubMed ID: 16085540
[TBL] [Abstract][Full Text] [Related]
9. Temporal expression profiling of the effects of secreted factors from prostate stromal cells on embryonal carcinoma stem cells.
Pascal LE; Vêncio RZ; Goo YA; Page LS; Shadle CP; Liu AY
Prostate; 2009 Sep; 69(12):1353-65. PubMed ID: 19455603
[TBL] [Abstract][Full Text] [Related]
10. Shwachman-Diamond syndrome: implications for understanding the molecular basis of leukaemia.
Dror Y
Expert Rev Mol Med; 2008 Dec; 10():e38. PubMed ID: 19102804
[TBL] [Abstract][Full Text] [Related]
11. [The role of stromal and hematopoietic tissue interaction in pathology of hematopoiesis].
Morozova VT
Klin Lab Diagn; 2003 Aug; (8):33-6. PubMed ID: 14524126
[No Abstract] [Full Text] [Related]
12. Control of hematopoiesis and apoptosis in MDS: more than FLIPing the coin.
Mhyre AJ; Deeg HJ
Leuk Res; 2007 Jun; 31(6):747-9. PubMed ID: 17320170
[No Abstract] [Full Text] [Related]
13. [Wilms tumor gene (WT1) expression in blood cells from patients with myelodysplastic syndrome].
Abdulkadyrov KM; Gritsaev SV; Kapustin SI; Martynkevich IS; Blinov MN; Bessmel'tsev SS; Tiranova SA; Rugal' VI
Vopr Onkol; 2004; 50(6):668-71. PubMed ID: 15755060
[No Abstract] [Full Text] [Related]
14. Analysis of apoptosis regulatory genes expression in the bone marrow (BM) of adult de novo myelodysplastic syndromes (MDS).
Economopoulou C; Pappa V; Kontsioti F; Papageorgiou S; Kapsimali V; Papasteriadi C; Economopoulou P; Papageorgiou E; Dervenoulas J; Economopoulos T
Leuk Res; 2008 Jan; 32(1):61-9. PubMed ID: 17597205
[TBL] [Abstract][Full Text] [Related]
15. Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.
Blau O; Hofmann WK; Baldus CD; Thiel G; Serbent V; Schümann E; Thiel E; Blau IW
Exp Hematol; 2007 Feb; 35(2):221-9. PubMed ID: 17258071
[TBL] [Abstract][Full Text] [Related]
16. [Abnormal polarization of T lymphocyte induces negative hematopoietic regulation in myelodysplastic syndromes].
Wu LY; Li X; Chang CK; Ying SX; Pu Q
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):549-54. PubMed ID: 18078133
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow glycophorin-positive erythroid cells of myelodysplastic patients responding to high-dose rHuEPO therapy have a different gene expression pattern from those of nonresponders.
Cortelezzi A; Colombo G; Pellegrini C; Silvestris I; Moronetti Mazzeo L; Bosari S; Lambertenghi Deliliers G; Fracchiolla NS
Am J Hematol; 2008 Jul; 83(7):531-9. PubMed ID: 18383321
[TBL] [Abstract][Full Text] [Related]
18. [Myelodysplastic syndromes].
Matsuda A
Rinsho Ketsueki; 2009 Mar; 50(3):147-53. PubMed ID: 19352080
[No Abstract] [Full Text] [Related]
19. Regulation of global gene expression in the bone marrow microenvironment by androgen: androgen ablation increases insulin-like growth factor binding protein-5 expression.
Xu C; Graf LF; Fazli L; Coleman IM; Mauldin DE; Li D; Nelson PS; Gleave M; Plymate SR; Cox ME; Torok-Storb BJ; Knudsen BS
Prostate; 2007 Nov; 67(15):1621-9. PubMed ID: 17823924
[TBL] [Abstract][Full Text] [Related]
20. Expression of Dlk1 gene in myelodysplastic syndrome determined by microarray, and its effects on leukemia cells.
Qi X; Chen Z; Liu D; Cen J; Gu M
Int J Mol Med; 2008 Jul; 22(1):61-8. PubMed ID: 18575777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
